We are live on ! Find out more

OSIR

Osiris Therapeutics, Inc. Common Stock

OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

80 hedge funds and large institutions have $41M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New

Increased

Maintained

Reduced

Closed

53% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 19

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

1% less funds holding

Funds holding: 81 → 80 (-1)

59% less capital invested

Capital invested by funds: $100M → $41M (-$59M)

71% less call options, than puts

Call options by funds: $380K | Put options by funds: $1.33M

Holders

Holders Change

-1

Holders Change %

-1.23%

% of All Funds

2.13%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$380K

Puts

$1.33M

Net Calls

-$946K

Net Calls Change

+$2.72M

Top Buyers

Rank	Fund	Capital Flow
1	Two Sigma Investments New York	+$546K
2	D.E. Shaw & Co New York	+$541K
3	Jacobs Levy Equity Management Florham Park, New Jersey	+$404K
4	BFA BlackRock Fund Advisors San Francisco, California	+$258K
5	Morgan Stanley New York	+$179K

Top Sellers

Rank	Fund	Capital Flow
1	CCM Consonance Capital Management New York	-$23.3M
2	Fidelity Investments Boston, Massachusetts	-$1.14M
3	SIM Spark Investment Management New York	-$651K
4	Susquehanna International Group Bala Cynwyd, Pennsylvania	-$563K
5	Group One Trading Chicago, Illinois	-$455K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 AllianceBernstein Nashville, Tennessee	$216K	–	–	–
27	SAMC 27 Shinko Asset Management Company Tokyo, Japan	$201K	–	–	–
28	PCMI 28 Princeton Capital Management Inc Princeton, New Jersey	$199K	–	–	–
29	29 Millennium Management New York	$196K	+$115K	+16,441	+92%
30	30 Barclays London, United Kingdom	$175K	-$3.53K	-506	-1%
31	31 Swiss National Bank Zurich, Switzerland	$174K	+$40.5K	+5,800	+23%
32	32 ProShare Advisors Bethesda, Maryland	$158K	-$19.8K	-2,838	-9%
33	TA 33 Teachers Advisors New York	$158K	–	–	–
34	34 State Board of Administration of Florida Retirement System Tallahassee, Florida	$135K	–	–	–
35	CS 35 Credit Suisse Zurich, Switzerland	$133K	-$64.4K	-9,215	-28%
36	HK 36 Horizon Kinetics New York	$120K	–	–	–
37	37 California Public Employees Retirement System Sacramento, California	$114K	-$9.08K	-1,300	-6%
38	38 Citigroup New York	$114K	+$46.5K	+6,665	+50%
39	39 Bank of Montreal Toronto, Ontario, Canada	$113K	+$63K	+9,015	+83%
40	40 RhumbLine Advisers Boston, Massachusetts	$111K	+$2.02K	+290	+2%
41	41 Two Sigma Advisers New York	$109K	+$133K	+19,007	New
42	42 New York State Common Retirement Fund Albany, New York	$108K	–	–	–
43	43 Deutsche Bank Frankfurt Am Main Ge, Germany	$106K	-$188K	-26,864	-59%
44	CLOS 44 Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland	$103K	–	–	–
45	45 Federated Hermes Pittsburgh, Pennsylvania	$103K	+$126K	+18,038	New
46	46 Wells Fargo San Francisco, California	$99K	+$2.93K	+419	+2%
47	47 DekaBank Deutsche Girozentrale Frankfurt, Germany	$86K	-$9.08K	-1,300	-8%
48	VKH 48 Virtu KCG Holdings New York	$80K	+$98.1K	+14,044	New
49	49 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$75K	+$4.02K	+576	+4%
50	GC 50 Globeflex Capital San Diego, California	$74K	+$90.1K	+12,900	New

OSIR Hedge Fund Activity: Q1 2016 in Review

80 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q1 2016, worth a combined $41M — down 59% from $100M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of OSIR and 12 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 29 added.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $546K. The largest seller was Consonance Capital Management, exiting entirely with an estimated $23.3M sold.

80 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q1 2016, down from 81 in Q4 2015.
Funds reported $41M of Osiris Therapeutics, Inc. Common Stock stock for Q1 2016, down 59% quarter-over-quarter.
12 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q1 2016 and 13 closed out, a net change of -1 holder.
The largest Osiris Therapeutics, Inc. Common Stock buyer in Q1 2016 was Two Sigma Investments, an estimated $546K added.
The largest Osiris Therapeutics, Inc. Common Stock seller in Q1 2016 was Consonance Capital Management, an estimated $23.3M sold.

Based on aggregated 13F filings for Q1 2016.

Osiris Therapeutics, Inc. Common Stock OSIR